英国专利药价格管理政策述评

Review on Pricing Policy of Patent Drugs in UK

目的:评价英国专利药价格管理政策。方法:阐述英国专利药价格管理政策,并对其实施效果进行分析,最后总结其特点及适用条件。结果与结论:英国专利药价格管理政策在鼓励药品研发和创新方面起到很大作用,使英国的制药产业处于全球领先水平。但该政策体系并未充分体现药品的临床价值,不利于引导企业研发真正具有临床需求且成本-效果好的药品,并且在药品费用控制方面作用有限。

OBJECTIVE： To evaluate the pricing policy on the patent drugs in UK. METHODS： The current pricing policy on patent drugs in UK and the outcome of the policy were analyzed and its characteristics and applicable condition were summarized. RESULTS ＆ CONCLUSIONS： Current pricing policy on patent drugs in UK provided incentives for the research ＆ development as well as innovation of drugs and it helped to keep UK＇s pharmaceutical industries in the global leading level. However, there is no mechanism within it to take explicit account of therapeutic value of drugs. Also, it provides weak incentives to invest in the most costeffective yet clinically demanded drugs and it has limited effect on price control of drugs.